Which supplement cuts liver fat best? new trial aims to find out.
NCT ID NCT07194863
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test two supplements — essential phospholipid and betaine HCL/L-glutamic acid — in 200 adults with metabolic fatty liver disease (MAFLD). The goal is to see which one reduces fat in the liver more effectively. Participants will be followed for a period to measure changes in liver fat using imaging.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- essential phospholipid and betaine HCL/L-glutamic acid
- What this could lead to
- If it works, this could point toward a simple supplement option to help control fatty liver disease.
- What could go wrong
- This is an early-stage trial with no results yet. The supplements may not reduce liver fat better than each other, and long-term benefits are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a quick liver scan replace needle biopsies for MASH in diabetics?
- Mushroom supplement shows promise for fatty liver in new trial
- Gut bug tied to fatty liver? scientists launch probe
- Stomach bug linked to fatty liver? new study investigates
- Amino acid supplement may help fatty liver – new study
- Home HIIT bike workout targets fatty liver in new trial